State Street Corporation 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 1:46 pm Sale | 2023-12-31 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 1,861,919 1.890% | -410,006 (-18.05%) | Filing |
| 2023-10-10 11:16 am Sale | 2023-09-30 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 2,271,925 2.310% | -11,717,507 (-83.76%) | Filing |
| 2023-05-10 09:16 am Purchase | 2023-04-30 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 13,989,432 14.240% | 8,053,973 (+135.69%) | Filing |
| 2023-02-03 09:54 am Purchase | 2022-12-31 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 5,935,459 6.110% | 5,935,459 (New Position) | Filing |